These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22294182)

  • 1. Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.
    Kelly P; Paulin F; Lamont D; Baker L; Clearly S; Exon D; Thompson A
    Br J Cancer; 2012 Feb; 106(5):955-61. PubMed ID: 22294182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy.
    Kelly P; Appleyard V; Murray K; Paulin F; Lamont D; Baker L; Suttie S; Exon D; Thompson A
    Br J Cancer; 2010 Jul; 103(2):232-8. PubMed ID: 20551956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
    Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
    Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Protocol in Esophageal Adenocarcinoma.
    Kelly P
    Methods Mol Biol; 2018; 1756():281-293. PubMed ID: 29600378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease.
    Tumblin A; Tailor A; Hoehn GT; Mack AK; Mendelsohn L; Freeman L; Xu X; Remaley AT; Munson PJ; Suffredini AF; Kato GJ
    Haematologica; 2010 Sep; 95(9):1467-72. PubMed ID: 20378559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination of normal and esophageal cancer plasma proteomes by MALDI-TOF mass spectrometry.
    Schwacke J; Millar TP; Hammond CE; Saha A; Hoffman BJ; Romagnuolo J; Hill EG; Smolka AJ
    Dig Dis Sci; 2015 Jun; 60(6):1645-54. PubMed ID: 25577268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma.
    Xue A; Chang JW; Chung L; Samra J; Hugh T; Gill A; Butturini G; Baxter RC; Smith RC
    Br J Cancer; 2012 Nov; 107(11):1883-91. PubMed ID: 23169340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.
    Xue A; Scarlett CJ; Chung L; Butturini G; Scarpa A; Gandy R; Wilson SR; Baxter RC; Smith RC
    Br J Cancer; 2010 Jul; 103(3):391-400. PubMed ID: 20588270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined biomarker pattern improves the discrimination of lung cancer.
    Liu L; Liu J; Wang Y; Dai S; Wang X; Wu S; Wang J; Huang L; Xiao X; He D
    Biomarkers; 2011 Feb; 16(1):20-30. PubMed ID: 20964562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
    Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
    Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
    Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
    Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
    Shevchenko VE; Arnotskaya NE; Zaridze DG
    Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma.
    Grus FH; Joachim SC; Sandmann S; Thiel U; Bruns K; Lackner KJ; Pfeiffer N
    Mol Vis; 2008 Aug; 14():1437-45. PubMed ID: 18682810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
    Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S
    J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum proteomic profiles of the subjects with esophageal precancerous and cancerous lesions from Linzhou, an area with high incidence of esophageal cancer in Henan Province, Northern China].
    Wang LD; Wang DC; Zheng S; Fan ZM; Li JL; Feng CW; Zhang YR; Liu B; Gao SS; He X; Feng XS
    Ai Zheng; 2006 May; 25(5):549-54. PubMed ID: 16687072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
    Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic biomarker predicts therapeutical effects of oxaliplatin combining with fluoropyrimidine in metastatic gastric cancer patients by the SELDI-proteinchip platform.
    Yu Z; Yu JK; Fang XF; Yuan Y; Shen H
    Hepatogastroenterology; 2013 Oct; 60(127):1800-4. PubMed ID: 24624447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of plasma proteins associated with oesophageal cancer chemotherapeutic treatment outcomes using SWATH-MS.
    Guo N; Minas G; Synowsky SA; Dunne MR; Ahmed H; McShane R; Bhardwaj A; Donlon NE; Lorton C; O'Sullivan J; Reynolds JV; Caie PD; Shirran SL; Lynch AG; Stewart AJ; Arya S
    J Proteomics; 2022 Aug; 266():104684. PubMed ID: 35842220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).
    Gast MC; van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
    Clin Chem Lab Med; 2009; 47(6):694-705. PubMed ID: 19416081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.